Molecular signature of methotrexate response among rheumatoid arthritis patients

BACKGROUND: Methotrexate (MTX) is the first line treatment for rheumatoid arthritis (RA), but failure of satisfying treatment response occurs in a significant proportion of patients. Here we present a longitudinal multi-omics study aimed at detecting molecular and cellular processes in peripheral bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Brynedal, Boel, Yoosuf, Niyaz, Ulfarsdottir, Tinna Bjorg, Ziemek, Daniel, Maciejewski, Mateusz, Folkersen, Lasse, Westerlind, Helga, Müller, Malin, Sahlström, Peter, Jelinsky, Scott A., Hensvold, Aase, Padyukov, Leonid, Pomiano, Nancy Vivar, Catrina, Anca, Klareskog, Lars, Berg, Louise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084884/
https://www.ncbi.nlm.nih.gov/pubmed/37051216
http://dx.doi.org/10.3389/fmed.2023.1146353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084884/
https://www.ncbi.nlm.nih.gov/pubmed/37051216
http://dx.doi.org/10.3389/fmed.2023.1146353

Ejemplares similares